Thalidomide is distributed into human semen after oral dosing

Drug Metabolism and Disposition

Volumn 29, Issue 10, 2001, Pages 1355-1357

  Teo, Steve K ^a   Harden, Jill L ^b   Burke, Alison B ^b   Noormohamed, Faruq H ^c   Youle, Mike ^d   Johnson, Margaret A ^d   Peters, Barry S ^e   Stirling, David I ^a   Thomas, Steve D ^a  

^a CELGENE CORPORATION   (United States)

^b Bioanalytical Department   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; THALIDOMIDE;

ADULT; ARTICLE; ATMOSPHERIC PRESSURE; BIRTH DEFECT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; SEMEN ANALYSIS; SERODIAGNOSIS; TANDEM MASS SPECTROMETRY; VIRUS LOAD;

EID: 0034822474     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Thalidomide revisited: Pharmacology and clinical applications
2. Thalidomide is an inhibitor of angiogenesis
3. Effects of thalidomide on gastrointestinal toxic effects of irinotecan
4. Assessment of the effectiveness of animal development toxicity testing for human safety
5. Pharmacokinetics and hemodynamic effects of single oral doses of thalidomide in asymptomatic human immunodeficiency virus-infected subjects
6. Thalidomide: Current uses
7. Thalidomide
8. Antitumor activity of thalidomide in refractory multiple myeloma
9. Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers
10. Safety profile of thalidomide after 53 weeks of oral administration in Beagle dogs
11. Thalidomide single-dose proportionality assessment in healthy subjects
12. Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: Interaction with oral hexachlorobenzene
13. S. T. E. P. S.: A comprehensive program for controlling and monitoring access to thalidomide